(Press-News.org) Quality of life measures tend to be most useful for clinical decision-making in trials in which quality of life is the primary outcome, according to a recent study published online January 7 in The Journal of the National Cancer Institute.
There has been increasing interest in the value of patient-reported symptom assessment in trials and their potential usage as primary or secondary endpoints in new trials. Both the World Health Organization and the U.S. Food and Drug Administration have endorsed quality of life, but they are not always incorporated into trials because of the additional resources needed for data collection. But quality of life measures remain important for women who have completed therapy and many have symptoms such as fatigue, cognitive complaints, sleep and sexual problems, and neuropathy. At the other end of the spectrum, for advanced breast cancer patients on palliative treatments with toxicities, it would be important to determine if any observed survival benefit is outweighed by that burden.
To determine how quality of life measures are used in clinical trials, Julie Lemieux, M.D., of the Université Laval in Québec, Canada, and colleagues, conducted a literature search for articles that reported a randomized clinical trial of breast cancer treatment in which quality of life was an endpoint.
Their review included 190 randomized clinical trials—103 on biomedical interventions, and 87 on non-biomedical interventions, such as psychosocial interventions like the effect of group therapy on patient outcomes.
The authors found that QOL measures were most useful for clinical decisions in trials using non-biomedical interventions.
They also found that quality of life measurements should be included as a secondary endpoint in adjuvant therapy trials only when the medical outcome is expected to be about the same, or if the study focuses on a vulnerable population such as the elderly; or tests a new intervention for which quality of life information needs to be obtained. They should also be included in metastatic breast cancer trials when a minimal survival difference is expected; or treatments have substantial differences in toxicity.
They also write that when QOL is not the primary endpoint of a trial, "QOL results should ideally appear in a companion article published at the same time as the traditional medical outcomes article so that a full view of the risks and benefits of the intervention can be presented at the same time to clinicians."
In an accompanying editorial, Patricia A. Ganz, M.D., of UCLA, writes, "The large increase in the number of published studies identified in this high-quality systematic review reflects the increased acceptance of the patient's voice in assessing the outcome of trials as well as the participation of expert QOL investigators in the design, conduct, and analysis of clinical trials."
Ganz also writes, "Inclusion of well-validated measures of relevant symptoms should be a high priority for assessing the burden of breast cancer treatments, whether in survivors of breast cancer or in women with advanced disease receiving palliative care."
INFORMATION:
Contact:
Article: Geneviève Dupuis, Director of Communications, Centre hospitalier affilié universitaire de Québec (CHA)
418 649-5587, genevieve.dupuis.cha@ssss.gouv.qc.ca
Editorial: Patricia A. Ganz, pganz@mednet.ucla.edu
Quality of life measures in breast cancer clinical trials
2011-01-08
ELSE PRESS RELEASES FROM THIS DATE:
College students lack scientific literacy, study finds
2011-01-08
EAST LANSING, Mich. — Most college students in the United States do not grasp the scientific basis of the carbon cycle – an essential skill in understanding the causes and consequences of climate change, according to research published in the January issue of BioScience.
The study, whose authors include several current and former researchers from Michigan State University, calls for a new way of teaching – and, ultimately, comprehending – fundamental scientific principles such as the conservation of matter.
"Improving students' understanding of these biological principles ...
Clinical waste management needs specialized regulation
2011-01-08
A study carried out by the University of Granada (UGR) warns of the need to unify existing plans for clinical waste management in the different autonomous communities to improve recycling and waste disposal. There is currently no specific state-wide regulation, just a framework law that the Spanish Ministry of the Environment and Rural and Marine Affairs (MARM) is planning to reform.
"We carried out a comparison of the clinical waste management regulations and plans in place in the autonomous communities in 2008 to see if there were any differences. We observed distinctions ...
VIB-K.U. Leuven scientists clear the way to alternative anti-angiogenic cancer therapy
2011-01-08
Leuven – Scientists attached to VIB and K.U.Leuven have succeeded in decoding a potential new anti-cancer mechanism. The researchers discovered that normalizing abnormal tumor blood vessels through HRG (histidine-rich glycoprotein) prevents metastasis of tumor cells and enhances chemotherapy efficiency. In tumors, vessels formation is disturbed, leading to inefficient delivery of chemotherapeutic drugs and allowing cancer cells to escape to other parts of the body (metastasis). The normalization of tumor blood vessel formation through HRG works by repressing the production ...
Lessons learned from oil rig disaster
2011-01-08
When interviewed by the BBC, the now retired BP boss Tony Hayward admitted to his company's insufficient response to the Deepwater Horizon rig accident in the Gulf of Mexico. Could the company have been better prepared for what turned out to be one of the biggest oil disasters in history?
"We were making it up day to day," Hayward said of BP's rescue plan. Together with chairman of the board, Carl-Henrik Svenberg, he was held responsible for 11 dead and 17 injured workers. According to the New York Times, five million barrels of oil leaked into the ocean outside the coast ...
For ever and ever: When the wedding flight never ends
2011-01-08
Its stay on this planet was actually meant to be a very short one. Male twisted-wing parasites (Strepsiptera) usually have a life span of only few hours. However, accidentally a specimen of Mengea tertiara, about the size of an aphid, became preserved for 'eternity': during its wedding flight about 42 million years ago it was caught in a drop of tree resin and subsequently almost perfectly conserved in a piece of amber.
PD Dr. Hans Pohl of Friedrich Schiller University Jena (Germany) calls this "a very exceptional stroke of luck." Together with colleagues from Jena, Hamburg ...
A pesky bacterial slime reveals its survival secrets
2011-01-08
Cambridge, Mass., January 7, 2011 – By rethinking what happens on the surface of things, engineers at Harvard University have discovered that Bacillus subtilis biofilm colonies exhibit an unmatched ability to repel a wide range of liquids—and even vapors.
Centimeters across yet only hundreds of microns thick, such slimy bacterial coatings cling to the surfaces of everything from pipes to teeth and are notoriously resistant to antimicrobial agents. The researchers now suspect they know the secret to a biofilm's resiliency.
Published in the January 5th early edition of ...
Researchers pinpoint origin of deadly brain tumor
2011-01-08
Scientists have identified the type of cell that is at the origin of brain tumors known as oligodendrogliomas, which are a type of glioma – a category that defines the most common type of malignant brain tumor.
In a paper published in the December 2010 issue of the journal Cancer Cell, investigators found that the tumor originates in and spreads through cells known as glial progenitor cells – cells that are often referred to as "daughter" cells of stem cells. The work comes at a time when many researchers are actively investigating the role that stem cells which have ...
Rice U. research shows Starbucks' logo redesign could prove beneficial to company
2011-01-08
Despite U.S. consumers' threats of protests in response to the redesigned Starbucks logo unveiled yesterday, the new look may be a smart move in the long run as the coffee company expands into Asian markets, according to a Rice University researcher who has studied consumer reaction to logos.
"The logo of a brand is much more than a pictorial representation of the brand," said Rice Professor of Marketing Vikas Mittal, who has co-authored two studies on customers, logos and brand commitment. "For consumers who are highly committed to the brand, the logo represents a visual ...
Most consumers want predictive tests to learn if a disease is in their future
2011-01-08
BOSTON, Mass.––Consumers may place a high value on information to predict their future health, and may be willing to pay out of pocket to get it. In a national survey conducted by researchers at Tufts Medical Center, roughly 76% of people indicated that they would take a hypothetical predictive test to find out if they will later develop Alzheimer's disease, breast or prostate cancer, or arthritis. On average, respondents were willing to pay $300 to $600, depending on the specific disease and the accuracy of the test.
Published online in the journal Health Economics, ...
Bendy tubes get around
2011-01-08
Theo Odijk, you win. The professor of biotechnology at Delft University of Technology in the Netherlands has a new best friend in Rice University's Matteo Pasquali.
Together with collaborators at the French National Center for Scientific Research (CNRS), the University of Bordeaux, France, and Vrije University, Amsterdam, the Rice professor and his team have settled a long-standing controversy in the field of polymer dynamics: The researchers proved once and for all that Odijk was correct in proclaiming that a little flexibility goes a long way for stiff filaments in ...